Is Ayahuasca Legal in Oregon? (2026)

Instrument

Schedule I, hallucinogenic substances (federal schedule adopted as the Oregon schedule)

Source

https://www.ecfr.gov/current/title-21/section-1308.11

Retrieved

2026-10-31

Fingerprint

32b7d6331a0f6f0a

Hallucinogenic substances.
  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers):

(1) Alpha-ethyltryptamine

7249

Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET.

(2) 4-bromo-2,5-dimethoxy-amphetamine

7391

Some trade or other names: 4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA

(3) 4-Bromo-2,5-dimethoxyphenethylamine

7392

Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.

(4) 2,5-dimethoxyamphetamine

7396

Some trade or other names: 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA

(5) 2,5-dimethoxy-4-ethylamphet-amine

7399

Some trade or other names: DOET

(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)

7348

(7) 4-methoxyamphetamine

7411

Some trade or other names: 4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA

(8) 5-methoxy-3,4-methylenedioxy-amphetamine

7401

(9) 4-methyl-2,5-dimethoxy-amphetamine

7395

Some trade and other names: 4-methyl-2,5-dimethoxy-α-methylphenethylamine; “DOM”; and “STP”

(10) 3,4-methylenedioxy amphetamine

7400

(11) 3,4-methylenedioxymethamphetamine (MDMA)

7405

(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA

7404

(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA

7402

(14) 3,4,5-trimethoxy amphetamine

7390

(15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT

7431

(16) Alpha-methyltryptamine (other name: AMT)

7432

(17) Bufotenine

7433

Some trade and other names: 3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine

(18) Diethyltryptamine

7434

Some trade and other names: N,N-Diethyltryptamine; DET

(19) Dimethyltryptamine

7435

Some trade or other names: DMT

(20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)

7439

(21) Ibogaine

7260

Some trade and other names: 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1′, 2′:1,2] azepino [5,4-b] indole; Tabernanthe iboga

(22) Lysergic acid diethylamide

7315

(23) Marihuana

7360

(24) Mescaline

7381

(25) Parahexyl—7374; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl.

(26) Peyote

7415

Meaning all parts of the plant presently classified botanically as
Lophophora williamsii Lemaire,
 whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts

(Interprets
21 USC 812(c)
, Schedule I(c) (12))

(27) N-ethyl-3-piperidyl benzilate

7482

(28) N-methyl-3-piperidyl benzilate

7484

(29) Psilocybin

7437

(30) Psilocyn

7438

(31) Tetrahydrocannabinols

7370

(i) Meaning tetrahydrocannabinols, except as in
paragraph (d)(31)(ii)
 of this section, naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:

1 cis or trans tetrahydrocannabinol, and their optical isomers

6 cis or trans tetrahydrocannabinol, and their optical isomers

3, 4 cis or trans tetrahydrocannabinol, and its optical isomers

(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)

 (ii) Tetrahydrocannabinols does not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in
7 U.S.C. 1639
o
.

(32) Ethylamine analog of phencyclidine

7455

Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE

(33) Pyrrolidine analog of phencyclidine

7458

Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP

(34) Thiophene analog of phencyclidine

7470

Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP

(35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine

7473

Some other names: TCPy

(36) 4-methylmethcathinone (Mephedrone)

1248

(37) 3,4-methylenedioxypyrovalerone (MDPV)

7535

(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)

7509

(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)

7508

(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)

7519

(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)

7518

(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)

7385

(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)

7532

(44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)

7517

(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)

7521

(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)

7524

(47) 3,4-Methylenedioxy-N-methylcathinone (Methylone)

7540

(48) (1-pentyl-1
H
-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)

(7144)

(49) [1-(5-fluoro-pentyl)-1
H
-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11)

(7011)

(50)
N
-(1-adamantyl)-1-pentyl-1
H
-indazole-3-carboxamide (APINACA, AKB48)

(7048)

(51) quinolin-8-yl 1-pentyl-1
H
-indole-3-carboxylate (PB-22; QUPIC)

(7222)

(52) quinolin-8-yl 1-(5-fluoropentyl)-1
H
-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)

(7225)

(53)
N
-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1
H
-indazole-3-carboxamide (AB-FUBINACA)

(7012)

(54)
N
-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1
H
-indazole-3-carboxamide (ADB-PINACA)

(7035)

(55) 2-(4-iodo-2,5-dimethoxyphenyl)-
N-
(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe)

(7538)

(56) 2-(4-chloro-2,5-dimethoxyphenyl)-
N-
(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe)

(7537)

(57) 2-(4-bromo-2,5-dimethoxyphenyl)-
N-
(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe)

(7536)

(58) Marihuana Extract

7350

Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, containing greater than 0.3% delta-9-tetrahydrocannabinol on a dry weight basis, other than the separated resin (whether crude or purified) obtained from the plant.

(59) 4-methyl-
N
-ethylcathinone (4-MEC)

(1249)

(60) 4-methyl-
alpha
-pyrrolidinopropiophenone (4-MePPP)

(7498)

(61)
alpha
-pyrrolidinopentiophenone (α-PVP)

(7545)

(62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB)

(7541)

(63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone)

(1246)

(64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP)

(7542)

(65) 4-fluoro-
N
-methylcathinone (4-FMC; flephedrone)

(1238)

(66) 3-fluoro-
N
-methylcathinone (3-FMC)

(1233)

(67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone)

(1258)

(68)
alpha
-pyrrolidinobutiophenone (α-PBP)

(7546)

(69)
N
-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1
H
-indazole-3-carboxamide (AB-CHMINACA)

(7031)

(70)
N
-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1
H
-indazole-3-carboxamide (AB-PINACA)

(7023)

(71) [1-(5-fluoropentyl)-1
H
-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)

(7024)

(72)
N
-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1
H
-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)

(7032)

(73) methyl 2-(1-(5-fluoropentyl)-1
H
-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA)

7034

(74) methyl 2-(1-(5-fluoropentyl)-1
H
-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB)

7033

(75)
N
-(adamantan-1-yl)-1-(5-fluoropentyl)-1
H
-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48)

7049

(76)
N
-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1
H
-indazole-3-carboxamide (Other names: ADB-FUBINACA)

7010

(77) methyl 2-(1-(cyclohexylmethyl)-1
H
-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA)

7042

(78) methyl 2-(1-(4-fluorobenzyl)-1
H
-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA)

7020

(79) methyl 2-(1-(4-fluorobenzyl)-1
H
-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA)

(7021)

(80) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone)

7547

(81) Naphthalen-1-yl 1-(5-fluoropentyl)-1
H
-indole-3-carboxylate (Other names: NM2201; CBL2201)

7221

(82)
N
-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1
H
-indazole-3-carboxamide (Other name: 5F-AB-PINACA)

7025

(83) 1-(4-cyanobutyl)-
N
-(2-phenylpropan-2-yl)-1
H
-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78)

7089

(84) methyl 2-(1-(cyclohexylmethyl)-1
H
-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA)

7044

(85) 1-(5-fluoropentyl)-
N
-(2-phenylpropan-2-yl)-1
H
-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA)

7085

(86)
N
-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one)

7543

(87) methyl 2-(1-(4-fluorobutyl)-1
H
-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)

7043

(88) 1-(4-methoxyphenyl)-
N
-methylpropan-2-amine (other names:
para
-methoxymethamphetamine, PMMA)

(1245)

(89) ethyl 2-(1-(5-fluoropentyl)-1
H
-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)

7036

(90) methyl 2-(1-(5-fluoropentyl)-1
H
-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)

7041

(91)
N
-(adamantan-1-yl)-1-(4-fluorobenzyl)-1
H
-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))

7047

(92) 1-(5-fluoropentyl)-
N
-(2-phenylpropan-2-yl)-1
H
-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)

7083

(93) (1-(4-fluorobenzyl)-1
H
-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144)

7014

(94)
N
-Ethylhexedrone (Other names: α-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one)

7246

(95)
alpha-
Pyrrolidinohexanophenone (Other names: α
-
PHP; α-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)

7544

(96) 4-Methyl-
alpha
-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)

7245

(97) 4′-Methyl-
alpha
-pyrrolidinohexiophenone (Other names: MPHP; 4′-methyl-
alpha
-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)

7446

(98)
alpha
-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)

7548

(99) 4′-Chloro-
alpha
-pyrrolidinovalerophenone (Other names: 4-chloro-α-PVP; 4′-chloro-α-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)

7443

(100) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)

7286

(101) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB)

7549

(102)
N
-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1
H
-indazole-3-carboxamide (other name: ADB-BUTINACA)

7027

(103) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: α-PiHP;
alpha
-PiHP)

7551

(104) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)

1259

(105) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone;
N,N
-dimethylpentylone)

7552

(106) 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one)

1239

(107) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)

7118

(108) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)

7201

(109) 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP)

7457

(110) methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1
H
-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA)

7090

(111) Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA)

7091

(112)
N
-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1
H
-indazole-3-carboxamide (other name: ADB-4en-PINACA)

7092

(113) Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201)

7094

(114) Methyl 2-(1-(4-fluorobenzyl)-1
H
-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA)

7095

(115) 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6
H
-benzo[
c
]chromen-1-ol (other names: hexahydrocannabinol, HHC)

7220

(116) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151)

7093

(117) Diphenidine (other name: 1-(1,2-diphenylethyl)piperidine)

7292

Instrument

Schedule III, depressants (federal schedule adopted as the Oregon schedule)

Source

https://www.ecfr.gov/current/title-21/section-1308.13

Retrieved

2026-10-31

Fingerprint

4f67cff777df1677

Depressants.
  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

(1) Any compound, mixture or preparation containing:

(i) Amobarbital

2126

(ii) Secobarbital

2316

(iii) Pentobarbital

2271

or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

(2) Any suppository dosage form containing:

(i) Amobarbital

2126

(ii) Secobarbital

2316

(iii) Pentobarbital

2271

or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.

(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof

2100

(4) Chlorhexadol

2510

(5) Embutramide

2020

(6) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act

2012

(7) Ketamine, its salts, isomers, and salts of isomers

7285

[Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone]

(8) Lysergic acid

7300

(9) Lysergic acid amide

7310

(10) Methyprylon

2575

(11) Perampanel, and its salts, isomers, and salts of isomers

2261

(12) Sulfondiethylmethane

2600

(13) Sulfonethylmethane

2605

(14) Sulfonmethane

2610

(15) Tiletamine and zolazepam or any salt thereof

7295

Some trade or other names for a tiletamine-zolazepam combination product:

Telazol

Some trade or other names for tiletamine:

2-(ethylamino)-2-(2-thienyl)-cyclohexanone

Some trade or other names for zolazepam:

4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-
e
] [1,4]-diazepin-7(1
H
)-one, flupyrazapon

Instrument

OAR 855-080-0021 (Schedule I) as filed BP 8-2020, eff. 06/23/2020

Source

https://records.sos.state.or.us/ORSOSWebDrawer/Record/7604711/File/document

Retrieved

2026-10-08

Fingerprint

b00bb0868fdfca45

RULE TITLE: Schedule I NOTICE FILED DATE: 04/21/2020 RULE SUMMARY: Schedule I controlled substances in Oregon RULE TEXT: (1) Schedule I consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in 21CFR part 1308.11, and unless specifically excepted or unless listed in another schedule, any quantity of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (a) 1,4-butanediol; (b) Gamma-butyrolactone (c) Methamphetamine, except as listed in OAR 855-080-0022; (d) Dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide (U-47700) (e) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene]benzenesulfonamide (W-18) and positional isomers thereof, and any substituted derivative of W-18 and its positional isomers, and their salts, by any substitution on the piperidine ring (including replacement of all or part of the nitrophenylethyl group), any substitution on or replacement of the sulfonamide, or any combination of the above that are not FDA approved drugs, unless specifically excepted or when in the possession of an FDA registered manufacturer or a registered research facility, or a person for the purpose of sale to an FDA registered manufacturer or a registered research facility. (f) Substituted derivatives of cathinone and methcathinone that are not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or are not FDA approved drugs, including but not limited to, (A) Methylmethcathinone (Mephedrone); (B) Methylenedioxypyrovalerone (MDPV); (C) Methylenedioxymethylcathinone (Methylone); (D) 2-Methylamino-3’,4’-(methylenedioxy)-butyrophenone (Butylone); (E) Fluoromethcathinone (Flephedrone); (F) 4-Methoxymethcathinone (Methedrone). (2) Schedule I also includes any compounds in the following structural classes (2a–2k) and their salts, that are not FDA approved drugs, unless specifically excepted or when in the possession of an FDA registered manufacturer or a registered research facility, or a person for the purpose of sale to an FDA registered manufacturer or a registered research facility: (a) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Examples of this structural class include but are not limited to: JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, AM-1220, MAM-2201 and AM-2201; (b) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Examples of this structural class include but are not limited to: JWH-167, JWH -201, JWH-203, JWH-250, JWH-251, JWH-302 and RCS-8; (c) Benzoylindoles: Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Examples of this structural class include but are not limited to: RCS-4, AM-694, AM-1241, and AM-2233; (d) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5- position of the phenolic ring whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural Page 2 of 4 class include but are not limited to: CP 47,497 and its C8 homologue (cannabicyclohexanol); (e) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (f) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (g) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl) indene structure with substitution at the 3-position of the indene ring whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent; (h) Cyclopropanoylindoles: Any compound containing an 3-(cyclopropylmethanoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent and whether or not substituted in the cyclopropyl ring to any extent. Examples of this structural class include but are not limited to: UR- 144, XLR-11 and A-796,260; (i) Adamantoylindoles: Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples of this structural class include but are not limited to: AM- 1248 and AB-001; (j) Adamantylindolecarboxamides: Any compound containing an N-adamantyl-1-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples of this structural class include but are not limited to: STS-135 and 2NE1; and (k) Adamantylindazolecarboxamides: Any compound containing an N-adamantyl-1-indazole-3-carboxamide with substitution at the nitrogen atom of the indazole ring, whether or not further substituted in the indazole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples of this structural class include but are not limited to: AKB48. (3) Schedule I also includes any other cannabinoid receptor agonist that is not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or is not an FDA approved drug. (4) Schedule I also includes any substituted derivatives of fentanyl that are not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or are not FDA approved drugs, and are derived from fentanyl by any substitution on or replacement of the phenethyl group, any substitution on the piperidine ring, any substitution on or replacement of the propanamide group, any substitution on the phenyl group, or any combination of the above. (5) Schedule I also includes any compounds in the following structural classes (a – b), and their salts, that are not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or FDA approved drugs, unless specifically excepted or when in the possession of an FDA registered manufacturer or a registered research facility, or a person for the purpose of sale to an FDA registered manufacturer or a registered research facility: (a) Benzodiazepine class: A fused 1,4-diazepine and benzene ring structure with a phenyl connected to the diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine or benzene ring, any substitution(s) on the phenyl ring, or any combination thereof. Examples of this structural class include but are not limited to: Clonazolam, Flualprazolam (b) Thienodiazepine class: A fused 1,4-diazepine and thiophene ring structure with a phenyl connected to the 1,-4- diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine or thiophene ring, any substitution(s) on the phenyl ring, or any combination thereof. Examples of this structural class include but are not limited to: Etizolam (6) Exceptions. The following are exceptions to subsection (1) of this rule: (a) 1, 4-butanediol and gamma-butyrolactone when in the possession of a person for the purpose of its sale to a legitimate manufacturer of industrial products and the person is in compliance with the Drug Enforcement Administration requirements for List I Chemicals; Page 3 of 4 (b) 1, 4-butanediol and gamma-butyrolactone when in the possession of a person for the purpose of the legitimate manufacture of industrial products; (c) Marijuana and delta-9-tetrahydrocannabinol (THC).